A CAV3 microdeletion differentially affects skeletal muscle and myocardium

Neurology

Volumn 61, Issue 11, 2003, Pages 1513-1519

  Cagliani, R ^a,d   Bresolin, N ^a,b,c   Prelle, A ^b   Gallanti, A ^b,c   Fortunato, F ^b   Sironi, M ^a   Ciscato, P ^b   Fagiolari, G ^b   Bonato, S ^b   Galbiati, S ^b   Corti, S ^b   Lamperti, C ^b   Moggio, M ^b   Comi, G P ^b,c  

^a Associazione La Nostra Famiglia   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ctro di Eccellenza Malat Neurodeg   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 3; DYSTROPHIN; NITRIC OXIDE SYNTHASE; PHENYLALANINE; UTROPHIN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; DISTAL MYOPATHY; ELECTRON MICROSCOPY; GENE DELETION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HEART MUSCLE; HEART MUSCLE BIOPSY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; MUSCLE BIOPSY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; WESTERN BLOTTING;

EID: 10744228916     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000097320.35982.03     Document Type: Article

References (31)

1. Anderson RG. The caveolae membrane system. Annu Rev Biochem 1998;67:199-225. Review.
2. Galbiati F, Razani B, Lisanti MP. Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 2001;7:435-441. Review.
3. Engelman JA, Zhang XL, Galbiati F, Lisanti MP. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett 1998;429:330-336.
4. Scherer PE, Lewis RY, Volonte D, et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 1997;272:29337-29346.
5. Song KS, Scherer PE, Tang Z, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996;271:15160-15165.
6. Tang Z, Scherer PE, Okamoto T, et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996;271:2255-2261.
7. Minetti C, Sotgia F, Bruno C, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998;18:365-368.
8. Betz RC, Schoser BG, Kasper D, et al. Mutations in CAV-3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001;28:218-219.
9. Vorgerd M, Ricker K, Ziemssen F, et al. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 2001;57:2273-2277.
10. Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000;54:1373-1376.
11. Merlini L, Carbone I, Capanni C, et al. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV3) gene. J Neurol Neurosurg Psychiatry 2002;73:65-67.
12. Tateyama M, Aoki M, Nishino I, et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002;58:323-325.
13. Fischer D, Schroers A, Blumcke I, et al. Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol 2003;53:233-241.
14. McNally EM, de Sa Moreira E, Duggan DJ, et al. Caveolin-3 in muscular dystrophy. Hum Mol Genet 1998;7:871-877.
15. Dubowitz V. Muscle biopsy, a pratical approach. 2nd ed. Philadelphia: Baillière Tindall, 1985.
16. Nicholson LV, Davison K, Falkous G, et al. Dystrophin in skeletal muscle. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 1989;94:137-146.
17. Prelle A, Comi GP, Tancredi L, et al. Sarcoglycan deficiency in a large Italian population of myopathic patients. Acta Neuropathol 1998;96:509-514.
18. Anderson LV, Davison K, Moss JA, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999;8:855-861.
19. Estournet B, Romero NB, Mercuri E, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001;69:1198-1209.
20. Crosbie RH, Barresi R, Campbell KP. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J 2002;16:1786-1791.
21. Prelle A, Comi GP, Rigoletto C, et al. An atypical case of partial merosin deficiency congenital muscular dystrophy. J Neurol 1997;244:391-395.
22. Repetto S, Bado M, Broda P, et al. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 1999;261:547-550.
23. Vaghy PL, Fang J, Wu W, Vaghy LP. Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 1998;431:125-127.
24. Matsuda C, Hayashi YK, Ogawa M, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001;10:1761-1766.
25. Venema VJ, Ju H, Zou R, Venema RC. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 1997;272:28187-28190.
26. Sotgia F, Lee JK, Das K, et al. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000;275:38048-38058.
27. Herrmann R, Straub V, Blank M, et al. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 2000;9:2335-2340.
28. Hagiwara Y, Sasaoka T, Araishi K, et al. Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 2000;9:3047-3054.
29. Woodman SE, Park DS, Cohen AW, et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002;277:38988-38997.
30. Rybin VO, Grabham PW, Elouardighi H, Steinberg SF. Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3. Am J Physiol Heart Circ Physiol 2003;285: H325-H332.
31. Scherer PE, Lewis RY, Volonte D, et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 1997;272:29337-29346.